首页>Journal of the American College of Cardiology>Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: Results from the SCD-HeFT (Sudden Cardiac death in heart failure trial)
Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: Results from the SCD-HeFT (Sudden Cardiac death in heart failure trial)
作者单位:St Vincent Heart Center of Indiana, Indianapolis, IN, United States[1]Seattle Institute for Cardiac Research, Seattle, WA, United States[2]Department of Medicine, Division of Cardiology, Duke University, Durham, NC, United States[3]Department of Statistics, Duke Clinical Research Institute, Duke University, Durham, NC, United[4]Department of Medicine, Division of Cardiology, University of Washington, 1959 Northeast Pacific[5]